Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Structure-activity relationship studies on thiaplidiaquinones A and B as novel inhibitors of Plasmodium falciparum and farnesyltransferase
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 3887739
Author(s) Cadelis, Melissa M.; Bourguet-Kondracki, Marie-Lise; Dubois, Joëlle; Kaiser, Marcel; Brunel, Jean Michel; Barker, David; Copp, Brent R.
Author(s) at UniBasel Kaiser, Marcel
Year 2017
Title Structure-activity relationship studies on thiaplidiaquinones A and B as novel inhibitors of Plasmodium falciparum and farnesyltransferase
Journal Bioorganic & medicinal chemistry
Volume 25
Number 16
Pages / Article-Number 4433-4443
Abstract Marine meroterpenoids, thiaplidiaquinones A and B and their respective non-natural dioxothiazine regioisomers have been shown to inhibit mammalian and protozoal farnesyltransferase (FTase) with the regioisomers exhibiting activity in the nanomolar range. In order to explore the structure-activity relationship (SAR) of this class of marine natural products, analogues of thiaplidiaquinones A and B and their regioisomers were synthesised, with variation in the number of isoprene units present in their side chains to afford prenyl and farnesyl analogues. The previously reported geranyl series of compounds were found to be the most potent FTase inhibitors closely followed by the novel farnesyl series. The prenyl series exhibited the most potent anti-plasmodial activity but the series was also the most cytotoxic. Overall, the farnesyl series exhibited moderate anti-plasmodial activity with one analogue, 14 also exhibiting low cytotoxicity, identifying it as a scaffold worthy of further exploration.
Publisher PERGAMON-ELSEVIER SCIENCE LTD
ISSN/ISBN 0968-0896
edoc-URL http://edoc.unibas.ch/55890/
Full Text on edoc Restricted
Digital Object Identifier DOI 10.1016/j.bmc.2017.06.029
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/28666857
ISI-Number WOS:000406023000021
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.370 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
03/05/2024